Alphapointe Awarded Summary Judgement in Patent CaseNews | December 18, 2020
A December 17 Kansas City Business Journal article highlighted the recent summary judgment in Alphapointe’s multiyear Tactical Medical Tourniquet (TMT) patent dispute. After four years of disputes with a for-profit competitor who claimed Alphapointe was infringing on its patents, the decision effectively ends lawsuits between Alphapointe and Composite Resources.
Since 2012, nonprofit Alphapointe has been developing the TMT in conjunction with the military. The TMT is a significant improvement over what has previously been available for troops and has the potential to save numerous additional lives, as well as providing employment for more than 200 people with blindness or visual impairment.
Despite ongoing lawsuits, the U.S. Department of Defense approved Alphapointe’s TMT in May 2019. Now, more than 200,000 TMTs are being used by the military.